Drug intelligence / Profile preview

PED vaccine

Development stage
Preclinical
Lead developer
Pharos Biologicals
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
01

Overview

PED vaccine is a veterinary recombinant chimeric protein subunit vaccine being developed by Pharos Vaccine (also referred to as Pharos Biologicals) for the prevention of porcine epidemic diarrhea (PED). Porcine epidemic diarrhea virus (PEDV) is a highly contagious coronavirus that causes severe diarrhea and dehydration in pigs, leading to high mortality rates in suckling piglets. Unlike traditional inactivated or live-attenuated vaccines, this vaccine utilizes protein engineering platform technology to express chimeric recombinant proteins as immunogens, which avoids the safety risks associated with live pathogens and allows for rapid adaptation to viral mutations. The vaccine is currently in preclinical development, specifically in the formulation development stage.

Other names
Porcine epidemic diarrhea vaccine
02

Targets

Porcine epidemic diarrhea virus Spike glycoprotein

Beyond the preview

Go deeper on PED vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PED vaccine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call